Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.22.2.2
Warrants
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Warrants Warrants
In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") for the purchase of 2,552,913 shares of the Company's common stock at an exercise price of $0.42 per share to Finback Evolv II, LLC ("Finback"), a consulting group affiliated with one of the Company's shareholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA") and expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation – Stock Compensation as the warrants vest upon certain performance conditions being met (see Note 16).
In connection with the closing of the Merger, the Company assumed the Public Warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50. The Public Warrants are immediately exercisable and expire in July 2026. The Public Warrants are classified as a liability and recorded at their fair value of $23.6 million on the date of closing of the Merger with an offset to additional paid-in-capital and are subsequently remeasured to fair value at each reporting date based on the publicly available trading price. The change in fair value of the public warrant liability of
$(1.1) million and $4.3 million for the three and nine months ended September 30, 2022, respectively, was recognized as a component of other income (expense), net in the condensed consolidated statements of operations and comprehensive loss.
As of September 30, 2022 and December 31, 2021, warrants to purchase the following classes of Common Stock outstanding consisted of the following in the table below:
September 30, 2022
Issuance Date Contractual
Term
(in years)		 Underlying Equity
Instrument		 Balance Sheet
Classification		 Shares Issuable
Upon Exercise
of Warrant		 Weighted
Average
Exercise Price
January 13, 2021 10 Common stock Equity 2,552,913 $ 0.42
July 16, 2021 5 Common stock Liability 14,324,994 $ 11.50
    16,877,907
December 31, 2021
Issuance Date Contractual
Term
(in years)		 Underlying Equity
Instrument		 Balance Sheet
Classification		 Shares Issuable
Upon Exercise
of Warrant		 Weighted
Average
Exercise Price
January 13, 2021 10 Common stock Equity 2,552,913 $ 0.42
July 16, 2021 5 Common stock Liability 14,324,994 $ 11.50
16,877,907